Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Erasmus MC Cancer Institute

InstitutionResearch output, impact & collaborations

Erasmus MC Cancer Institute is a research organisation in Rotterdam, NL. OpenAlex records 13,355 works and 1,413,391 citations for it. 3,743 researchers list it as their most recent affiliation.

13,355
Works
1,413,391
Citations
3,743
Researchers
70.4
Avg h-index

How has Erasmus MC Cancer Institute's publication output changed over time?

ScholarIQpublication output · 2003–2022

Output grew0% over the shown period — from 1 works in 2003 to 1 in 2022.

1
1
1
1
1
1
2
1
1
1
2003200420052006200820092012201420152022

Who are the most-cited researchers behind Erasmus MC Cancer Institute?

ScholarIQtop researchers by citations
1
Anja Wagner · Genetic factors in colorectal cancer
191 works15,176 citations
2
Tessa M. van Ginhoven · Thyroid Cancer Diagnosis and Treatment
119 works2,227 citations
3
Gaston J H Franssen · Neuroendocrine Tumor Research Advances
60 works2,029 citations

What are the most-cited papers on Erasmus MC Cancer Institute?

ScholarIQmost cited works
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
Pieter van Hagen, Maarten C.C.M. Hulshof, J. Jan B. van Lanschot, Ewout W. Steyerberg, Mark I. van Berge Henegouwen, Bas P. L. Wijnhoven, Dick J. Richel, Grard A. P. Nieuwenhuijzen, Geke A.P. Hospers, Johannes J. Bonenkamp, Miguel A. Cuesta, R.J.B. Blaisse, Olivier R. Busch, F.J.W. ten Kate, G.J. Creemers, C.J.A. Punt, John Theodorus Plukker, Henk M.W. Verheul, Ernst Jan Spillenaar Bilgen, Herman van Dekken, Maurice J.C. van der Sangen, Tom Rozema, Katharina Biermann, Jannet C. Beukema, Anna H.M. Piet, Caroline M. van Rij, Janny G. Reinders, H.W. Tilanus, Ate van der Gaast
New England Journal of Medicine. 20125,537 CitationsOPEN ACCESS
Screening and Prostate-Cancer Mortality in a Randomized European Study
Fritz H. Schröder, Jonas Hugosson, Monique J. Roobol, Teuvo L.J. Tammela, Stefano Ciatto, Vera Nelen, Maciej Kwiatkowski, Marcos Lujan, Hans Lilja, Marco Zappa, Louis Denis, Franz Recker, Antonio Berenguer, Liisa Määttänen, Chris H. Bangma, Gunnar Aus, Arnauld Villers, Xavier Rebillard, Theodorus van der Kwast, B. G. Blijenberg, Sue M. Moss, Harry J. de Koning, Anssi Auvinen
New England Journal of Medicine. 20094,027 CitationsOPEN ACCESS
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
Joël Shapiro, J. Jan B. van Lanschot, Maarten C.C.M. Hulshof, Pieter van Hagen, Mark I. van Berge Henegouwen, Bas P. L. Wijnhoven, Hanneke W.M. van Laarhoven, Grard A. P. Nieuwenhuijzen, Geke A.P. Hospers, Johannes J. Bonenkamp, Miguel A. Cuesta, R.J.B. Blaisse, Olivier R. Busch, Fiebo J.W. ten Kate, Geert-Jan Creemers, Cornelis J.A. Punt, John Th. M. Plukker, Henk M.W. Verheul, Ernst Jan Spillenaar Bilgen, Herman van Dekken, Maurice J.C. van der Sangen, Tom Rozema, Katharina Biermann, Jannet C. Beukema, Anna H.M. Piet, Caroline M. van Rij, Janny G. Reinders, Hugo W. Tilanus, Ewout W. Steyerberg, Ate van der Gaast
The Lancet Oncology. 20152,588 Citations
Gastroenteropancreatic neuroendocrine tumours
Irvin M. Modlin, Kjell Öberg, Daniel C. Chung, Robert T. Jensen, Wouter W. de Herder, Rajesh V. Thakker, Martyn Caplin, Gianfranco Delle Fave, Gregory Kaltsas, Eric P. Krenning, Steven F. Moss, Ola Nilsson, Guido Rindi, Ramón Salazar, Philippe Ruszniewski, Anders Sundin
The Lancet Oncology. 20081,754 Citations
Extended Transthoracic Resection Compared with Limited Transhiatal Resection for Adenocarcinoma of the Esophagus
Jan B.F. Hulscher, Johanna W. van Sandick, Angela G. E. M. de Boer, Bas P. L. Wijnhoven, Jan G.P. Tijssen, Paul Fockens, Peep F. M. Stalmeier, Fiebo J.W. ten Kate, Herman van Dekken, H. Obertop, Hugo W. Tilanus, J. Jan B. van Lanschot
New England Journal of Medicine. 20021,648 CitationsOPEN ACCESS

How much of the research on Erasmus MC Cancer Institute is open access?

ScholarIQopen access share
58%OPEN ACCESS
Gold
0%
Green
33%
Hybrid
8%
Bronze
17%
Closed
42%

Related on ScholarIQ

Glioma Diagnosis and Treatment
Top Topic
Cancer Genomics and Diagnostics
Top Topic
Advanced Radiotherapy Techniques
Top Topic
Cancer Immunotherapy and Biomarkers
Top Topic
Multiple Myeloma Research and Treatments
Top Topic
Breast Cancer Treatment Studies
Top Topic
470M+ articles · free account